Kailera Therapeutics, Inc. (KLRA)
NASDAQ:KLRA
Want to see KLRA full AI Analyst Report?
KLRA Analyst Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
KLRA Stock 12 Month Forecast
Average Price Target
$45.00
| Highest Price Target$57.00 | Average Price Target$45.00 | Lowest Price Target$30.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TD Cowen
$57
Buy
―
Reiterated
05/21/26
William Blair
―
Buy
―
Reiterated
05/16/26
Evercore ISI
―
Buy
―
Initiated
05/12/26
Jefferies
$48
Buy
―
Initiated
05/12/26
J.P. Morgan
$30
Buy
―
Initiated
05/12/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TD Cowen
$57
Buy
―
Reiterated
05/21/26
William Blair
―
Buy
―
Reiterated
05/16/26
Evercore ISI
―
Buy
―
Initiated
05/12/26
Jefferies
$48
Buy
―
Initiated
05/12/26
J.P. Morgan
$30
Buy
―
Initiated
05/12/26
Best Analysts Covering Kailera Therapeutics, Inc.
3 Months
Success Rate
0/1 ratings generated profit
Average Return
-10.00%
Copying Yaron Werber's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -10.00% per trade.
1 Year
Success Rate
0/1 ratings generated profit
Average Return
-10.00%
Copying Yaron Werber's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -10.00% per trade.
2 Years
Success Rate
0/1 ratings generated profit
Average Return
-10.00%
Copying Yaron Werber's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -10.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
KLRA Analyst Recommendation Trends
Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
0
0
0
3
Buy
0
0
0
0
4
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
7
Each month's total comprises the sum of three months' worth of ratings.
KLRA Financial Forecast
KLRA Stock Forecast FAQ
What is KLRA’s average 12-month price target, according to analysts?
Based on analyst ratings, Kailera Therapeutics, Inc.’s 12-month average price target is 45.00.
What is KLRA’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for KLRA, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is KLRA a Buy, Sell or Hold?
Kailera Therapeutics, Inc. has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
What is Kailera Therapeutics, Inc.’s price target?
The average price target for Kailera Therapeutics, Inc. is 45.00. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $57.00 ,the lowest forecast is $30.00. The average price target represents N/A Increase from the current price of N/A.
The highest analyst price target is $57.00 ,the lowest forecast is $30.00. The average price target represents N/A Increase from the current price of N/A.
What do analysts say about Kailera Therapeutics, Inc.?
Kailera Therapeutics, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
How can I buy shares of KLRA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.